Literature DB >> 2353828

Polyprenoic acid, E-5166, is effective in inhibiting the proliferation of keratinocytes in vitro.

M Koji1, T Kanzaki, A Takashima.   

Abstract

E-5166 is a newly synthesized polyprenoic acid that has been reported to control epithelial differentiation and to have antiproliferative effects on various tumor cells in vitro. This study examined the effects of E-5166 on the proliferation of keratinocytes. Three kinds of keratinocytes were used: normal human keratinocytes, a human trichilemmoma-derived K-TL-1 cell line, and a Pam 212 cell line. Cell proliferation was measured by 3H-thymidine incorporation and also by determining cell numbers. E-5166 was found to have significant antiproliferative effects on each of the cell lines studied. When Pam 212 cells were cultured in the presence of E-5166, cell proliferation was inhibited in a dose-dependent fashion. The inhibitory effect appeared to be reversible, since removal of E-5166 from the culture medium resulted in a subsequent return of cell proliferation. For normal human keratinocytes and K-TL-1 cells, E-5166 inhibited 3H-thymidine incorporation in a dose-dependent fashion. Furthermore, E-5166 showed significantly stronger antiproliferative capacity than Ro 10-9359, one of the aromatic retinoids, on Pam 212 cells and normal human keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353828     DOI: 10.1007/bf00493473

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  [Effect of a new synthetic retinoid (E-5166) on the differentiation of cultured human keratinocytes].

Authors:  N Okada; N Ikeda; Y Kitano; K Yoshikawa
Journal:  Nihon Hifuka Gakkai Zasshi       Date:  1988-01

2.  A survey of transformation markers in differentiating epidermal cell lines in culture.

Authors:  S H Yuspa; P Hawley-Nelson; B Koehler; J R Stanley
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

3.  The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors.

Authors:  F O Cope; B D Howard; R K Boutwell
Journal:  Experientia       Date:  1986-09-15

4.  Morphological, biological, and biochemical characteristics of a benign human trichilemmoma cell line in vivo and in vitro.

Authors:  T Kanzaki; H Eto; A Umezawa; T Maeda; H Iwase; M Ito
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

5.  Regulation of terminal differentiation of cultured human keratinocytes by vitamin A.

Authors:  E Fuchs; H Green
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

6.  Relationships between structure and activity of retinoids.

Authors:  M B Sporn; N M Dunlop; D L Newton; W R Henderson
Journal:  Nature       Date:  1976-09-09       Impact factor: 49.962

7.  Inhibition of ultraviolet-B skin carcinogenesis by all-trans-retinoic acid regimens that inhibit ornithine decarboxylase induction.

Authors:  M J Connor; N J Lowe; J H Breeding; M Chalet
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

8.  Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation.

Authors:  J A Fontana
Journal:  Exp Cell Biol       Date:  1987

9.  Arotinoid-ethylester. Effectiveness in refractory cutaneous T-cell lymphoma.

Authors:  E Hoting; K Meissner
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

Review 10.  Systemic retinoid therapy for psoriasis.

Authors:  N J Lowe; V Lazarus; L Matt
Journal:  J Am Acad Dermatol       Date:  1988-07       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.